Search for a rare disease
Other search option(s)
Diethylstilbestrol syndrome
Disease definition
A malformation syndrome reported in offspring (children and grandchildren) of women exposed to diethylstilbestrol (DES) during pregnancy and is characterized by reproductive tract malformations, decreased fertility and increased risk of developing clear cell carcinoma of the vagina and cervix in young women. Reproductive malformations reported in DES syndrome include small, T-shaped uteri and other uterotubal anomalies that increase the risk of miscarriages in women and epididymal cysts, microphallus, cryptorchidism, or testicular hypoplasia in men. DES, a synthetic nonsteroidal estrogen was widely prescribed from 1940-1970 to prevent miscarriage.
ORPHA:1916
Classification level: Disorder- Synonym(s):
- DES embryofetopathy
- DES syndrome
- Diethylstilbestrol embryofetopathy
- Distilbene embryofetopathy
- Prevalence: Unknown
- Inheritance: Not applicable
- Age of onset: All ages
- ICD-10: Q86.8
- ICD-11: LB44.6
- OMIM: -
- UMLS: C0853695
- MeSH: -
- GARD: -
- MedDRA: 10012780
A summary on this disease is available in Español (2015) Français (2015) Italiano (2015) Nederlands (2015) Deutsch (2002)
Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.